Hoechst Marion Roussel Report issue

Contributed to NME For profit Phase 1 Phase 2
Founded: Frankfurt Germany (1995)
Status: Acquired by Aventis (1999) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
1999
NCT00002150
First Marketed Drug
1995
streptokinase (streptase)
First NDA Approval
1998
rifapentine (priftin)
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree